Redefining Care Delivery: The Use of CGMs for Type 2 Diabetes
Learn how the newest care delivery options can help you better serve the type 2 diabetes population
Onduo's Virtual Care Model: CGM Spotlight
If you're in the business of supporting the type 2 diabetes population, you know this condition is one of the leading drivers of healthcare costs, lost productivity, and death in the U.S. Companies that can provide more personalized care solutions, instead of one-size-fits-all, are starting to see lasting and sustainable health and business outcomes.
In this report you'll learn:
- Why the intermittent use of continuous glucose monitoring systems (CGM) is beneficial to personalizing care
- How a virtual care model that leverages data from these sensors can help you match people with the right level of care
- What positive effects CGM-enabled care is having on glycemic control, diabetes distress, and time-in-range
Telcare BGM® is a registered trademark of Telcare LLC. a BioTelemetry Inc.
Dexcom® and Dexcom G6® are registered trademarks of Dexcom, Inc. Dexcom® If your glucose readings do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
Onduo offers certain care management and coordinated clinical care programs for eligible individuals, as further described within the website. Onduo LLC and a network of affiliated professional entities (collectively, "Onduo") collaborate to offer the services. Onduo services are meant to be used in conjunction with regular in-person clinical services and not intended to replace routine primary care.